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O&&rives. The purpose ofthis study was to compare clinical 
outcomes and tilt test variables between a single-stage tilt test with 
an infusion of 5 Amin of isoproterenol and a conventional 
multistage test with infusions of 0,2 and 5 Ccg/min of isoproterenol 
in three successive stages, 
Background. The diagnosis ofneu~omediated syncope isoften 
established with isoproterenol-head-up tilt tab1 
work has suggested that a singlr! infusion of 5 
terenol during 80’ head-up tilt for 40 min sbou 
establish t e 
Methods. ierts with recurrent syncope underwent 
both tests in 12ed crossover fashion. 
Restis. Of 24 patients with positive findings on a multistage 
test, 19 (79%) had positive findings on a single-stage test, whereas 
13 (81%) of 16 patients with negative r sults ltistage test 
had negative r sults on a single-stage test (p chiquare 
Neuromediated syncope isa newly described syndrome that 
is probably the cause of most syncope in the community 
(l-4). The diagnosis of neuromediated syncope is made on 
the basis of a history of recurrent syncope, an absence of 
other proven causes of syncope and a positive outcome on 
tilt table testing. Current protocols are often lengthy, may 
involve ither prolonged drug-free head-up tilt or a series of 
graduated isoproterenol infusions, intraarterial monitoring 
or central venous cannulas and may last up to 90 min. There 
is no agreement onan optimal protocol, but a simple, rapid, 
reproducible, well tolerated tilt table test might contribute o
an understanding of the prevalence, pathophysiology, treat- 
ment and prognosis of neuromediated syncope. 
To this end, we (5) previously evaluated the contribution 
of isoproterenol-tilt table testing to the diagnosis ofsyncope. 
We showed that presyncope and syncope are equivalent 
outcomes, an infusion of isoproterenol5 &min contributes 
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rate was 136 I 25 
analysis). 
multistage tilt tests ak-e 
-- 
most heavily to diagnostic outcome and a head 
only 5 to 7 min optimizes diagnostic yield ( 
trough rate-pressure p oduct 59,000 mm I-I 
identified positive tests. This suggested the feasibility of a 
very brief tilt table test that uses only a single infusion of 
isoproterenol at 5 pg/min, In this study, we utilized a 
prospective, randomized, crossover protocol to compare 
this single-stage tilt table test with a conventional multistage 
tilt table test with regard to clinical outcome, timing of onset 
of symptoms and hemodynamic changes before and during 
syncope or presyncope. 
Study patients. The study group consisted of 40 sequen- 
tially consenting patients referred for assessment of syncope 
who underwent tilt table testing if they had had 1) two or 
more syncopal episodes, 2) one syncopal episode and four or 
more presyrrcopal episodes, or 3) a single pisode of syncope 
causing serious injury. Patients with structural heart disease, 
documented ventricular tachycardia or bifascicular block 
also underwent ambulatory electrocardiography andpro- 
grammed electrical stimulation using a previously described 
protocol (5). Tilt table tests and electrophysiologic studies 
were performed on separate days. No patients underwent tilt 
table testing while taking beta-adrenoceptor bl cking agents, 
disopyramidt: or drugs with antjcholinergic activity. 
07351097/93/$6.00 
10 min. The last s 
dose infusion of 5 pg/min of isoprot 
edical Ethics committee. After con- 
Cents were randomly allocated to 
unconsciousness characterized by spontaneous recovery or 
recovery while in the supine position. Presyncope was 
defined as a state of light-headedness, usually associated 
with one or more symptoms ofdecreased vision, the sensa- 
tion of hearing voices distantly, slow response times to 
verbal stimuli, nausea, vomiting or partial loss of postural 
tone, that substantially reproduced the clinical presyncope 
of the patient. Based on our previous work (3, tilt tests were 
deemed to be positive if they ended in syncope or presyn- 
ase in heart rate-systolic pressure pro 
es&s are expressed as mean value + S 
Student r tests (paired or unpaired) were used to compare 
differences between pairs of groups. The correlation of 
continuous vartables between groups was determined by 
linear egression analysis. The chi-square or Fisher exact 
test was used to determine the statistical significance of
Chical ~~ara~te~~c~cs of the 4 - - -_. 
fj:Jrc,Jn] &Jf 
“. 
~omvent~gm~ ntt 
TaMe Test 
Total - --_- P 
BS3tlUlQS ; -.mwe bkgahve Vahe 
NO. 40 24 16 - 
Age iyrj SO? 19 $5 t 19 57 2 16 O.A& 
No. male 19 10 9 NS 
Syncopal episodes (no.) 
Wean 183 + 4001 240 I 489 91 t 173 MS 
Median 30 36 20 - 
Duration of symptoms (mo) 
Mean 8% lr I45 86k 124 49277 NS 
Median 25 14 18 - 
Forty patients with syncope underwent both tilt table tests I B + 13 days 
(median 7) apart. They were grolapcd arcording to the outcome of tite 
conventiona! multistage tilt table test. 
es actuarial survi 
cted at a level of 
single-stage test, 16 
was not statistical1 
multistage t st resu 
positive multistage t s 
single-stage test result. 
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Figure 1. Top panel, Time course of onset of presyncope during 
infusion of 5 &min of isoproterenol in the single-stage (II = 221 and 
muiristage in = ;iU} tiit teble protocols. Bottom d, Curves are fit 
to the data with the monoexponential equation x = a (1 - eSkf), 
where x represents the number of symptomatic patients, a repre- 
sents the total number of patients and t represents theduration of
head-up tilt in minutes. Curves were not forced to pass through the 
origin x= Q, t = 0. The half-time to syncope during the single-stage 
test was 1.3 min and during the multistage test was 2 min. 
tration of 5 &min of isoproteeenol. Of 19 patients with 
positive findings on both the single-stage and multistage 
tests, diagnostic symptoms first developed in1 patient iu the 
absence of isoproterenol, during administration f 2 &min 
of isoproterenol in 2 patients and during administration f 
5 &min of isoproterenol in 16. 
TInn$g of onset af symptoms. Figure I (top panel) com- 
pares the time course of the onset of presyncope during 
infusion of5 &min of isoproterenol in the single-stage and 
multistage t sts. The onset of presyncope occurred in an 
apparently monoexponential fashion over time in both tests 
and was essentially complete within 5 min of assumption f 
the head-up osition. Figure 1 (bottom panel) displays the 
same data as monoexponential decay curves. Fresynca~e 
tended to occur slightly more quickly in the single-stage 
Ihalf-time topresyncope 1.3 min) than in the multistage t st 
(half-time topresyncope 2 min), (p = 0.07 [NS!). 
The times at which presyncope fist occurred correlated 
well between tests. The data in Figure 2 show that in the 
ultistage Time, rnin 
Figure 2. Comparison f the time course of the onset of presyncope 
in 16 patients who developed pnsyncope during infusion of 5 &min 
of isoproterenol in both single-stage and multistage t!it table proto- 
cols. The line is drawra by linear egression a alysis, with a best fit 
equation of: Onset ime (single stage), min = 0.5 min + 0.5 [onset 
time (multistage)], min (r = 0.34, p = 0.001). The SEE is 0.9 min. 
The nunhers ia ~a~e~t~eses refer to the number of patients repro- 
sented by the relevant symbol. 
16 patients who developed presyrncope during iafusion of 
5 PgImin ofisoproterenol, there was a significant i:orr;elaticn 
of onset imes in both tests (r = 0.7 = OAOI; SEE 
0.9 min). 
Finally, we compared both protocols wit 
long presyncopal patients need to be ke 
waiting for syncope to occur. In the single-stage test, the 
-_ __ .- LllGiM ‘LiiIit: fr’irom prcsyncupc: to 3yucup VI --.--aua =JZ: 1.2 f 1.3 min. 
whereas in the multistage test the mean time from presyn- 
cope to syncope was 9.6 -C 1.6 min. During the single-stage 
test, 87% of patients who fainted id so within 2 min of the 
onset of presyncupe, whereas during the multistage t st, 
only 71% of patients who fainted id so within 2 min of the 
on 
ages. The changes in hemodynanaic 
variables in patients undergoing infusion of 5 pg/min of 
isoproterenol during head-up tilt are documented in Table 2. 
Thirty-seven patients underwent an infusion of 5 pg/min of 
isoproterenol during head-up tilt during both single-stage and 
multistage protocols. Mean peak heart rate, systolic blood 
pressure and rate-pressure product were very similar be- 
tween the two tests. Furthermore, peak variables for each 
patient correlated madestly but significantly between the 
two protocols (r= 0.50 to 0.65). Sixteen patients developed 
syncope or presyncope during infusion of 5 &min of 
isoproterenol during both protocols. Although mean trough 
heart rate, systolic blood pressure and rate-pressure product 
were very similar between the two tests, only r-rough eart 
rate for each patient correlated well between ~i:s two tests 
(r = 0.86, p -=c 0.001). The intertesj: intrapatient correlation 
between trough eart rates is depic?ed inFigure 3, as is the 
intertest intrapatient correlation between peak heart rates in 
the group of patients who developed presyncope orsyncope 
while receiving 5 pg/min of isoproter: nol during head-up tilt. 
No. of Rotocoi hear Regressim Test 
k&mts SingMirage Tlaree-Sea&e 
Peak heart rate (beats/r& 37 836 i- 25 133 + 98 
Peak systolic blood pressure (mm HE! 31 133 + 27 128 2 2s 
Peak rate-pressure pm&k3 (mm HgImin X IO31 37 17.1 r 4.4 18.0 c 4.8 
Trough heart rate (beatsknin) 86 76 k 31 
14 68 L 15 
Ia 4.8 k 2.0 4.6 ” 2.9 1.7 x 10’ (;.B I-B CO “.d” Y 
The paired data for peak from 37 patients who underwent infusions isoproterenol (5 &min) during both tilt table rotocols and for I6 patient5 who 
developed presyncope or syncope during both tests while receiving this i sion are presented. The trough blood pressure in two patients was 
scribed the use of incn 
~~g~~e 3. Intertest correlation of peak heart rates ( 
trough heart rates (&xw~ circles) in 16 patients who developed 
presyncope during infusion of 5 pg/rnin of isoproterenol in both 
single-stage and multistage tilt table protocols. The lines are drawn 
by linear regressicm analysis. Peak heart rate, r = 0.77, p < 0.001; 
trough heart rate, r = 0.86, p < 0.061. 
Psak heart rate 
Q 55 100 150 200 
Heart Rate. Multistage 
between tests, provided that the 
the longer protocol. 
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Findy, trough eart rates correlated wefl between tests 
and mean trough eart rates were statistically indistinguish- 
able. However, trough blood pressure did not Correlate well 
between the two protocols. Again, the relatively small SEE 
values point to the possible utility of these measures in
future studies. We (7) previously reported that rough eart 
rates reproduce well between tests under similar condirlons, 
but that trough blood pressures do not. Thus, the poor 
correlation of trough blood pressures between the single- 
stage and multistage t sts is not surprising. 
Patient tolerance. One possible shortcoming of a single- 
stage tilt table test is that he abrupt infusion of 5 pdrnin of 
isoproterenol might cause intolerable changes in heart rate 
or blood pressure. However, both peak heart rate and peak 
systolic blood pressure were very similar between the two 
protocols, Furthermore, the more rapid onset of [rresynco 
and shorter time between presyncope and syncope mig%t be 
expected tolead to greater acceptance bypatients. 
Limit&ions of the study. The major limitation 0” this 
study is that it does not deline ither the sensitivity or the 
specificity of the single-stage protocol. The former is un- 
avoidable in the absence of a reference standard test for 
neuromediated syncope. However, the single-stage t st 
compares well with the multistage t st by several criteria 
and the positive diagnostic yield of the latter test com- 
pares well with those of other published protocols (5). Thus, 
the sensitivities of the single-stage and multistage t sts are 
likely to be similar. More important, he specificity of 
isoproterenol-tilt table tests remains controversial (8). The 
patient groups that have been used in previous tudies 
(1,3,5,Y,lU) to estimate specificity generally have consisted 
of patients with other causes of syncope or patients with 
various kinds of heart disease. Neither of these groups is 
ideal. For example, patients with hypertension may have 
perturbed carotid baroreceptors, whereas patients who have 
had a myocasdiai nfarction may have perturbed autonomic 
nervous system function (11). A second potentially con- 
founding factor is the age of the subjects. Autonomic ner- 
vous system function changes with age (9-15) and we (16) 
have demonstrated sigi;ificant age-related differences in tilt 
table outcomes and hemodynamic changes. Inpatients with 
unexplained syncope, {he proportion of subjects with a 
positive isoproterenoLtilt tab:e test declines ignificantly 
with age, as does the abihty to develop a relative brady- 
cardia. This suggests hat the use in some studies (5) of 
control patients who were significantly older than those 
with neuromediated syncope might have overestimated 
specificity. Indeed, Kapoor and Brant (8) showed that the 
isoproterenol-tilt table test in their protocols was relatively 
nonspecific in yokmg patients. Thus, the response totilt table 
testing might depend significantly onthe age of the subject. 
~plieati9ns. At this time, we do not unreservedly advo- 
cate the use of this single-stage protocol for routine clinical 
use. Although this study demonstrates heusefulness of this 
procedure, it requires further scrutin 
specificity. We anticipate that among 
single-stage protocol be the assessmenr 0 
ity in a large group of ptomatic persons over a 
range and a compa of iso~~Qteren0~ and 
head-up tilt table testing. Finally, t 
how to provoke syncope in a brief 
which almost no syncope occurs 
Events in the first 10 mio of head-up tilt clearly require 
further pathophysioiogic stud In fact, studies 
laboratory currently use two f sequential heab 
tests in the absence and presence of5 
MOi. 
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